Global Health Impact Map
Cryptococcal Optimal ART Timing Trial
Activity Dates: 2010 to 2013
Country(ies): South Africa
The Cryptococcal Optimal Antiretroviral Therapy Timing (COAT) Trial was a NIH-sponsored randomized strategy trial to test whether early or deferred HIV therapy was the preferable strategy to optimize 6-month survival after cryptococcal meningitis. Collaborators from the University of Cape Town, Makerere University, and Mbarara University of Science and Technology, as well as the University of Minnesota collaborated on the trial running between 2010-2013.
Academic Health Center Units
Global Health Pathway
Doris Duke Clinical Research Fellowship Site, Fogarty Global Health Fellowship Site